Novel synthesis and crystallization of piperazine ring-containing compounds

Details for Australian Patent Application No. 2005201117 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Finkelstein, Nina; Singer, Claude; Liberman, Anita

Agent Spruson & Ferguson

Pub. Number AU-A-2005201117

Parent 43577

Filing date 15 March 2005

Wipo publication date 7 April 2005

International Classifications

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 487/12 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61P 025/24 Drugs for disorders of the nervous system

Event Publications

7 April 2005 Application Open to Public Inspection

  Published as AU-A-2005201117

7 April 2005 Complete Application Filed

20 October 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201118-Navigated pin placement for orthopaedic procedures

2005201116-Method for manufacturing bevel gears